However, the fundamental issue with Kind Patches lies in the biological impossibility of delivering meaningful doses of appetite-reducing compounds through the skin at levels that could affect weight loss
Kendall DM, Riddle MC, Rosenstock J, Zhuang D, Kim DD, Fineman MS, Baron AD
266(1): 32938 Li DP, Chen SR, Pan YZ, et al
Viswanathan P, Chaudhuri A, Bhatia R, Al-Atrash F, Mohanty P, Dandona P: Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin
Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development